Eurofirst News: Eurofirst 100, Eurofirst 250, and Eurofirst 500 investment news
Eurofirst market news from the Euronext Stock Exchange: Eurofirst 100, Eurofirst 250, and Eurofirst 400

Latest Eurofirst News:

  • European carmakers higher on Nissan gains

  • IBEX adds 1.42 percent on session

  • France Telecom gains over 8.5 percent on results

  • Banks see declines in Europe

  • European equities lower on renewed subprime worries

  • IBEX gains again amid European equities declines

  • Truck maker Man up on bids rumors

  • IBEX gains almost 1 percent on session

  • European utilities gain again

  • European equities lower on session

  • Euronext news feed


    Recommended equities news sites

  • Euronext
  • Euro Watch
  • FTSE News
  • Tokyo Market News
  • NYSE News
  • Mortgages & Loans
  •  

    August 15, 2006

    UBS up on quarterly report

    Filed under: UBS, Novartis, Sanofi-Aventis, Ericsson, SAP, STMicroelectronics, Akzo Nobel

    Down early in the day, the FTSE Eurofirst 300 managed to recover to close 0.9 percent higher to 1,355.41 on a slow day when some European markets were closed for the Assumption Day holiday.

    Stocks in technology sectors benefited from comments issued by Morgan Stanley. Among software companies, SAP added 2.7 percent to €143.08. STMicroelectronics was 4.1 percent higher to €12.29, while in the telecommunications equipment sector Ericsson gained 4.2 percent to SKr22.60.

    The pharmaceuticals sector was up on the day. Novartis was up by 1 percent to SFr69.95 even though its Sandoz generics division could be a target of a lawsuit by Sanofi-Aventis over unauthorized manufacture of generic copies of Plavix. The gain for Novartis came on a reconfirmation of Dresdner Kleinwort’s “buy” recommendation. Sanofi was also up, adding 2.5 percent to €70.30.

    Among banks, UBS was 3.4 percent higher to SFr68.30 on a second quarter report that showed a 47 percent gain in net profits, well above what had been expected.

    In the chemicals sector, Akzo Nobel added 4 percent to €44.35 on the news that it will ask shareholders to approve a spinoff of its pharmaceuticals unit and to make 30 percent of the new company available on Euronext in 2007.





    Latest Equities News:

  • Europe, US, most Asia markets lower on news, data

  • Equities decline globally on European debt concerns

  • Most global equities markets see declines on commodities prices

  • Europe, Asia markets mixed as Wall Street declines

  • European, US markets see gains as Asia markets remain mixed

  • European equities decline on lower credit rating for Greece

  • European equities markets gain, helped by US jobs report

  • Most global equities markets in decline

  • Europe, US, Asia markets all see declines

  • London markets see gains as most European markets retreat

  • Eurofirst News copyright 2012 Central Consultants